2017 Highlights. Hepatitis B and C in the Spotlight: a public health response in the Americas
Abstract
In 2016, PAHO published Hepatitis B and C in
the Spotlight: A public health response in the
Americas, the first regional report on viral
hepatitis. It provides an overview of the epidemiology
of hepatitis B (HBV) and hepatitis
C (HCV) in the Americas, and the national
responses implemented by countries and
territories in the Region.
The present report builds on the previous one,
and updates key aspects of public health
e orts to control the viral hepatitis epidemics
in the Region. The data included in this report
were submitted by countries and territories
(herein refereed to only as “countries”) in the
region to PAHO/WHO through the Country
Response Profile on Hepatitis B and C
(2016/2017) survey. Supplementary
information was also obtained from country
data mining exercises on viral hepatitis
developed in collaboration with PAHO.
Translated title
2017 aspectos destacados. Las hepatitis B y C bajo la lupa: la respuesta de salud pública en la Región de las Américas
Category of PAHO Strategic Plan 2014-2019
Collections
Related items
Showing items related by title, author, creator and subject.
-
Hepatitis B and C in the Spotlight. A public health response in the Americas, 2016
(Washington, D.C, PAHO, 2016-12)[Foreword]. This past May 2016, the World Health Organization (WHO) Member States endorsed the first “Global Health Sector Strategy on Viral Hepatitis 2016-2021” at the 69th World Health Assembly. This strategy will ... -
HIV, syphilis, and viral hepatitis among Latin American indigenous peoples and Afro-descendants: a systematic review
(2019-01)[ABSTRACT]. Objective. To identify and summarize existing literature on the burden of HIV, sexually transmitted infections (STIs), and viral hepatitis (VH) in indigenous peoples and Afrodescendants in Latin America to ... -
Fiscal Space for Health in Latin America and the Caribbean
(Washington, D.C., PAHO, 2020-06-30)Countries that have made the most progress toward universal coverage have public expenditures in health equivalent to at least 6% of their gross domestic product (GDP), which is the percentage established in PAHO’s universal ...
